Category: Biogen gains $1B in value after Goldman Sachs touts Alzheimer’s drug

Biogen gains $1B in value after Goldman Sachs touts Alzheimer’s drug

  1. Biogen gains $1B in value after Goldman Sachs touts Alzheimer’s drug  Boston Business Journal
  2. Goldman bets on Biogen’s potential ‘blockbuster’ Alzheimer’s drug  Fox Business
  3. Full coverage

from Business – Google News https://www.bizjournals.com/boston/news/2017/08/16/biogen-gains-1b-in-value-after-goldman-sachs.html

Advertisements